Abstract
Microorganisms are an extremely promising alternative to the extended use of pesticides for bio-control of plants. Pesticides are often expensive and accumulate in plants, having adverse effects on humans. Moreover, detection of undesirable chemical compounds in the food chain connected with the emergence of fungicide-resistant strains of pathogens calls for an alternative, non-polluting strategy for controlling plant diseases. Thus, biological control through the use of natural antagonistic microorganisms has emerged, for a long time; gram-negative bacteria have been intensively investigated as biological control agents. However, recently the attention has switched to the gram-positive members of the aerobic, spore-forming genus Bacillus. Bacillus amyloliquefaciens is an important Bacillus species because of its ability to produce different bioactive compounds with a broad spectrum of activity. The endeavor of this article is to review the literature on the utilization of bioactive compounds from Bacillus amyloliquefaciens in bio-control.
Keywords: Antagonistic, Bacillus amyloliquefaciens, bio-control, bioactive compounds, pesticide, fungicide-resistant strains, pathogens Quorum sensing, Quorum sensing, autoinducers, PGPR
The Natural Products Journal
Title: Bioactive Compounds Hold Up- Bacillus amyloliquefaciens as a Potent Bio-Control Agent
Volume: 1 Issue: 1
Author(s): M. Balhara, S. Ruhil, Sandeep Dhankhar and A. K. Chhillar
Affiliation:
Keywords: Antagonistic, Bacillus amyloliquefaciens, bio-control, bioactive compounds, pesticide, fungicide-resistant strains, pathogens Quorum sensing, Quorum sensing, autoinducers, PGPR
Abstract: Microorganisms are an extremely promising alternative to the extended use of pesticides for bio-control of plants. Pesticides are often expensive and accumulate in plants, having adverse effects on humans. Moreover, detection of undesirable chemical compounds in the food chain connected with the emergence of fungicide-resistant strains of pathogens calls for an alternative, non-polluting strategy for controlling plant diseases. Thus, biological control through the use of natural antagonistic microorganisms has emerged, for a long time; gram-negative bacteria have been intensively investigated as biological control agents. However, recently the attention has switched to the gram-positive members of the aerobic, spore-forming genus Bacillus. Bacillus amyloliquefaciens is an important Bacillus species because of its ability to produce different bioactive compounds with a broad spectrum of activity. The endeavor of this article is to review the literature on the utilization of bioactive compounds from Bacillus amyloliquefaciens in bio-control.
Export Options
About this article
Cite this article as:
Balhara M., Ruhil S., Dhankhar Sandeep and K. Chhillar A., Bioactive Compounds Hold Up- Bacillus amyloliquefaciens as a Potent Bio-Control Agent, The Natural Products Journal 2011; 1 (1) . https://dx.doi.org/10.2174/2210315511101010020
DOI https://dx.doi.org/10.2174/2210315511101010020 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) Meet Our Editorial Board Member
Current Genomics Discovery of Novel Regulatory Peptides by Reverse Pharmacology: Spotlight on Chemerin and the RF-amide Peptides Metastin and QRFP
Current Protein & Peptide Science Recent Developments in Anxiety Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Caveolin-1: A Promising Therapeutic Target for Diverse Diseases
Current Molecular Pharmacology Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Current Gene Therapy A Novel Class of Emerging Anticancer Compounds: Oxyprenylated Secondary Metabolites from Plants and Fungi
Current Medicinal Chemistry Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology Application of Microbial Biotransformation for the New Drug Discovery Using Natural Drugs as Substrates
Current Pharmaceutical Biotechnology Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Current Targeting Strategies for Adenovirus Vectors in Cancer Gene Therapy
Current Cancer Drug Targets Drosophila Neoplasias: Clues Towards the Understanding of Human Cancers
Current Genomics Editorial (Thematic Issue: Signalling Pathways in Anti-cancer Drug Resistance)
Current Medicinal Chemistry Wnt Signaling in Rhabdomyosarcoma – A Potential Targeted Therapy Option
Current Drug Targets Structural Features of the Interleukin-10 Family of Cytokines
Current Pharmaceutical Design A Review on the Use of Statins and Tocotrienols, Individually or in Combination for the Treatment of Osteoporosis
Current Drug Targets Modern Drug Discovery Technologies: Opportunities and Challenges in Lead Discovery
Combinatorial Chemistry & High Throughput Screening Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Patents on Non-Viral Mediated Gene Delivery
Recent Patents on DNA & Gene Sequences Embryonic Stem Cells: Overcoming the Immunological Barriers to Cell Replacement Therapy
Current Stem Cell Research & Therapy